Press Releases Gentian Diagnostics

Equities

GENT

NO0010748866

Market Closed - Oslo Bors Other stock markets 10:45:00 2024-06-11 am EDT			5-day change	1st Jan Change
45 ^NOK	-1.32%		+7.66%	+8.43%

Apr. 30	Gentian Diagnostics ASA Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 30	Transcript : Gentian Diagnostics ASA, Q1 2024 Earnings Call, Apr 30, 2024

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gentian Diagnostics : Production assistant - HQ based in Moss, Norway	May. 13	PU
Gentian Diagnostics : Application Sales Specialist (US based)	May. 13	PU
Gentian Diagnostics : 30 April 2024 - Quarterly Presentation - Q1 2024	Apr. 30	PU
Gentian Diagnostics : 30 April 2024 - Quarterly Report - Q1 2024	Apr. 30	PU
Gentian Diagnostics: New acting CEO and Chairperson of the Board of Directors	Apr. 29	AQ
Gentian Diagnostics : Scientists to Gentian’s R&D department	Apr. 08	PU
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference	Dec. 14	AQ
Gentian Diagnostics : Sales and Application Specialist - Nordic	23-10-10	PU
Gentian Diagnostics presents at the Pareto Healthcare Conference	22-09-07	AQ
Gentian Diagnostics : Invitation to presentation of second quarter results	22-08-18	PU
Gentian Diagnostics : signs distribution agreement with leading global diagnostics company for Cystatin C	22-04-20	PU
Gentian Diagnostics : SARS-CoV-2 Total Antibody Assay at IFCC EuroMedLab Munich 2022	22-04-06	PU
Gentian Diagnostics : Cystatin C at IFCC EuroMedLab in Munich 2022	22-04-04	PU
Gentian Diagnostics : Plasma and serum calprotectin at IFCC EuroMedLab Munich 2022	22-03-28	PU
Gentian Diagnostics : Meet us at IFCC EuroMedLab in Munich April 2022	22-03-21	PU
Gentian Diagnostics : Cystatin C as part of better kidney care	22-03-10	PU
FAQ: What is the value of calprotectin in blood as biomarker in IBD?	22-02-22	PU
Gentian Diagnostics : Invitation to presentation of 2021 fourth quarter results	22-02-11	PU
Webinar: «Calprotectin, a new routine inflammation biomarker »	22-02-03	PU
Available position: Product Manager (Temporary)	22-02-02	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Gentian Diagnostics

Equities

GENT

NO0010748866

Press Releases

Filters